These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
686 related articles for article (PubMed ID: 17475221)
21. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide. Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782 [TBL] [Abstract][Full Text] [Related]
22. Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells. Mi Q; Su BN; Chai H; Cordell GA; Farnsworth NR; Kinghorn AD; Swanson SM Anticancer Res; 2006; 26(2A):947-52. PubMed ID: 16619491 [TBL] [Abstract][Full Text] [Related]
23. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681 [TBL] [Abstract][Full Text] [Related]
24. Induction of G2/M arrest and apoptosis in human gastric epithelial AGS cells by aqueous extract of Agaricus blazei. Jin CY; Choi YH; Moon DO; Park C; Park YM; Jeong SC; Heo MS; Lee TH; Lee JD; Kim GY Oncol Rep; 2006 Dec; 16(6):1349-55. PubMed ID: 17089060 [TBL] [Abstract][Full Text] [Related]
25. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Huang WW; Ko SW; Tsai HY; Chung JG; Chiang JH; Chen KT; Chen YC; Chen HY; Chen YF; Yang JS Int J Oncol; 2011 Apr; 38(4):1067-73. PubMed ID: 21271215 [TBL] [Abstract][Full Text] [Related]
26. [(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis. Pojarová M; Kaufmann D; Gastpar R; Nishino T; Reszka P; Bednarski PJ; von Angerer E Bioorg Med Chem; 2007 Dec; 15(23):7368-79. PubMed ID: 17889547 [TBL] [Abstract][Full Text] [Related]
27. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. Chen YL; Lin SZ; Chang JY; Cheng YL; Tsai NM; Chen SP; Chang WL; Harn HJ Biochem Pharmacol; 2006 Jul; 72(3):308-19. PubMed ID: 16782069 [TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460. Shyu KG; Huang ST; Kuo HS; Cheng WP; Lin YL Acta Pharmacol Sin; 2007 Apr; 28(4):559-66. PubMed ID: 17376296 [TBL] [Abstract][Full Text] [Related]
30. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines. Mulligan JM; Greene LM; Cloonan S; Mc Gee MM; Onnis V; Campiani G; Fattorusso C; Lawler M; Williams DC; Zisterer DM Mol Pharmacol; 2006 Jul; 70(1):60-70. PubMed ID: 16571652 [TBL] [Abstract][Full Text] [Related]
31. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines. Whang YM; Park KH; Jung HY; Jo UH; Kim YH Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899 [TBL] [Abstract][Full Text] [Related]
32. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285 [TBL] [Abstract][Full Text] [Related]
33. Nuclear colocalization and interaction between bcl-xL and cdk1(cdc2) during G2/M cell-cycle checkpoint. Schmitt E; Beauchemin M; Bertrand R Oncogene; 2007 Aug; 26(40):5851-65. PubMed ID: 17369848 [TBL] [Abstract][Full Text] [Related]
34. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945 [TBL] [Abstract][Full Text] [Related]
35. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1. Chang LC; Yu YL; Liu CY; Cheng YY; Chou RH; Hsieh MT; Lin HY; Hung HY; Huang LJ; Wu YC; Kuo SC Cancer Chemother Pharmacol; 2015 Jun; 75(6):1303-15. PubMed ID: 25947085 [TBL] [Abstract][Full Text] [Related]
36. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro. Wu R; Ding W; Liu T; Zhu H; Hu Y; Yang B; He Q Cancer Lett; 2009 Nov; 285(1):13-22. PubMed ID: 19647933 [TBL] [Abstract][Full Text] [Related]
37. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK. Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148 [TBL] [Abstract][Full Text] [Related]
38. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Kasibhatla S; Baichwal V; Cai SX; Roth B; Skvortsova I; Skvortsov S; Lukas P; English NM; Sirisoma N; Drewe J; Pervin A; Tseng B; Carlson RO; Pleiman CM Cancer Res; 2007 Jun; 67(12):5865-71. PubMed ID: 17575155 [TBL] [Abstract][Full Text] [Related]
39. Smh-3 induces G(2)/M arrest and apoptosis through calcium‑mediated endoplasmic reticulum stress and mitochondrial signaling in human hepatocellular carcinoma Hep3B cells. Liu CY; Yang JS; Huang SM; Chiang JH; Chen MH; Huang LJ; Ha HY; Fushiya S; Kuo SC Oncol Rep; 2013 Feb; 29(2):751-62. PubMed ID: 23233035 [TBL] [Abstract][Full Text] [Related]
40. KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity. Yu CC; Liu SP; Hsu JL; Hsu JT; Kudryavtsev KV; Guh JH J Biomed Sci; 2015 Jan; 22(1):2. PubMed ID: 25563361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]